A Study on the Mechanism of Action of Isorhamnetin in the Treatment of Depression using Network Pharmacology, Molecular Docking Technology and Experimental Validation.

Zhang L, Wang S, Li Y, Li X, Yang Y, Wang L, Bai H

Open source

DOI
10.2174/0113892010485402260818104814
Published
2026 Aug 25
Container
Current pharmaceutical biotechnology
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2174/0113892010485402260818104814,
  title = {A Study on the Mechanism of Action of Isorhamnetin in the Treatment of Depression using Network Pharmacology, Molecular Docking Technology and Experimental Validation.},
  author = {Zhang L and Wang S and Li Y and Li X and Yang Y and Wang L and Bai H},
  year = {2026},
  journal = {Current pharmaceutical biotechnology},
  doi = {10.2174/0113892010485402260818104814},
  url = {https://doi.org/10.2174/0113892010485402260818104814}
}

RIS

TY  - JOUR
TI  - A Study on the Mechanism of Action of Isorhamnetin in the Treatment of Depression using Network Pharmacology, Molecular Docking Technology and Experimental Validation.
AU  - Zhang L
AU  - Wang S
AU  - Li Y
AU  - Li X
AU  - Yang Y
AU  - Wang L
AU  - Bai H
PY  - 2026
JO  - Current pharmaceutical biotechnology
DO  - 10.2174/0113892010485402260818104814
UR  - https://doi.org/10.2174/0113892010485402260818104814
ER  - 

APA

L, Z., S, W., Y, L., X, L., Y, Y., L, W., & H, B. (2026). A Study on the Mechanism of Action of Isorhamnetin in the Treatment of Depression using Network Pharmacology, Molecular Docking Technology and Experimental Validation.. Current pharmaceutical biotechnology. https://doi.org/10.2174/0113892010485402260818104814

Source records